Drug agency to screen product monograph prior to marketing

The Korea Food and Drug Administration has recently unveiled its plan to screen the contents of a drug’s insert paper which include product summary, pharmacological action and active ingredients prior to its launching to thoroughly assure drug safety in use.

The government plans to adopt the measure ten month on a trial basis starting December 1.

According to the KFDA, the screen results ...